By: Jenna Philpott
Intellia presented data from its Phase I study of NTLA-2001 at the 2024 American Heart Association scientific meeting in Chicago.
Jenna Philpott is a journalist who specializes in covering clinical trials, medical devices, and pharmaceutical technology. Her work has been featured in various publications, including Clinical Trials Arena, Medical Device Network, Pharmaceutical-Technology, and News Medical. She provides in-depth coverage of the latest developments in the healthcare industry, including FDA approvals, drug trials, and advancements in medical technology.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Jenna’s focus is primarily on healthcare and pharmaceuticals, with a strong emphasis on reporting press releases and citing data. She seems to be interested in the latest developments regarding FDA approvals, clinical trials, medical technology advancements, and innovations in pharmaceuticals.
Given Jenna's coverage attributes and themes covered, she would likely respond well to pitches that involve exclusive access to new research findings or insights into groundbreaking medical technologies. Additionally, offering expert commentary from reputable figures within the healthcare industry could also capture her attention.
It's important for sources reaching out to Jenna to provide fact-based information supported by credible data as her articles often cite such information. If your pitch aligns with these criteria while providing valuable insights into the topics she covers, it may have a higher chance of catching her interest.
This information evolves through artificial intelligence and human feedback. Improve this profile .